Assessing Delek US Hldgs: Insights From 6 Financial Analysts
Portfolio Pulse from Benzinga Insights
Six financial analysts have recently updated their ratings on Delek US Holdings (NYSE:DK), with a consensus indicating a neutral to somewhat bearish outlook. The average 12-month price target for DK has been raised to $29.17, reflecting an 8.72% increase from the previous target. Analysts from firms including Scotiabank, UBS, Mizuho, Wells Fargo, B of A Securities, and Piper Sandler have adjusted their price targets and ratings, suggesting varied expectations for the company's performance. Despite the adjustments, Delek's financial indicators such as revenue growth, net margin, ROE, ROA, and debt management present a mixed picture, with challenges in revenue growth and asset utilization but efficient cost management.
April 11, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Delek US Holdings has seen a range of analyst rating updates, with a new average 12-month price target of $29.17. Despite the neutral to somewhat bearish outlook from analysts, the company's financial health indicators such as revenue decline, net margin, and debt management suggest a cautious approach for investors.
The mixed analyst ratings and the adjustment in price targets reflect uncertainty and a cautious outlook for Delek US Holdings. The financial health indicators, including a significant revenue decline and high debt-to-equity ratio, underscore the challenges the company faces. However, the efficient cost management indicated by the net margin suggests some positive aspects. The overall neutral score reflects the balance between these factors and the uncertainty in the analysts' outlooks.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100